Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,208 | -131,120 | -96,552 | -66,465 | -32,786 |
| Depreciation Amortization | 815 | 2,403 | 1,904 | 1,333 | 684 |
| Accounts receivable | -20,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,212 | -27 | 1,098 | 1,846 | 579 |
| Other Working Capital | -23,676 | -2,273 | -1,962 | -2,463 | -1,425 |
| Other Operating Activity | 25,744 | 19,077 | 11,302 | 6,181 | 3,432 |
| Operating Cash Flow | $-39,113 | $-111,940 | $-84,210 | $-59,568 | $-29,516 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,632 | -187,668 | -66,815 | N/A | N/A |
| PPE Investments | -93 | -794 | -760 | -692 | -299 |
| Sale Of Investment | 30,000 | 17,500 | N/A | N/A | N/A |
| Investing Cash Flow | $6,275 | $-170,962 | $-67,575 | $-692 | $-299 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 141,267 | 141,748 | N/A | N/A |
| Debt Issued | 39,401 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,079 | 6,818 | 2,747 | 738 | 126 |
| Other Financing Activity | -1,123 | 127,252 | 127,252 | 127,252 | 127,252 |
| Financing Cash Flow | $42,357 | $275,337 | $271,747 | $127,990 | $127,378 |
| Beginning Cash Position | 190,335 | 197,900 | 197,900 | 197,900 | 197,900 |
| End Cash Position | 199,854 | 190,335 | 317,862 | 265,630 | 295,463 |
| Net Cash Flow | $9,519 | $-7,565 | $119,962 | $67,730 | $97,563 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,113 | -111,940 | -84,210 | -59,568 | -29,516 |
| Capital Expenditure | -93 | -794 | -760 | -692 | -299 |
| Free Cash Flow | -39,206 | -112,734 | -84,970 | -60,260 | -29,815 |